MSFrontier

OMNI-Can

Outcomes Mandate National Integration With Cannabis as Medicine
Status unknownPhase 2MS (type not specified)NCT03944447

What it found

No result found

We found no results in the registry or in papers.

What was tested

Treatment tested

  • Cannabis, Medical
  • RYAH-Medtech Inhaler

What it measured

Main measures

  • Prevention of COVID-19

    Five years

  • Treatment of COVID-19

    Five years

  • Treatment of Symptoms

    Five years

    PainQuality of life (reported by participants)Safety

Other measures (3)

  • Cannabis Impact on Quality of Life

    Five years

    Quality of life (reported by participants)

  • Cannabis Route and Dosing

    Five years

  • Monitoring Adverse Events

    Five years

    Safety

Who could take part

MS (type not specified) · 7 and over

Inclusion Criteria: * Clinical diagnosis of a Qualifying Condition for Medical Marijuana * Must be 18 years or older unless they have consent from their parent or legal guardian as defined under state law parameters * Must be willing to complete online surveys at baseline and the follow up points in this study Exclusion Criteria: * Pregnancy * Breastfeeding * Inability to provide informed consent * Inability to complete study visits or questionnaires * Active suicidality or psychosis, that could be exacerbated by the administration of cannabis

As registered. Criteria can change, so ask the trial team or your neurologist.

About this trial

In the sponsor's words

This will be a multistate, multicenter clinical study to determine the efficacy and safety of medical cannabis for a wide variety of chronic medical conditions.

Papers

    Loading reviews and guidelines…

    Related trials

    History

      1. Started

        Dec 2018

      2. Main results due

        Dec 2025

      3. Finished

        Dec 2025

      Assembled by software from public sources and not checked by people. Each record links to its source. Report an error